Single Dose of Gene Therapy AMT-061 Proves Effective in Hemophilia B
AMT-061, a gene therapy for people with severe hemophilia B, increased FIX activity levels in all patients enrolled in uniQure’s Phase 2b trial.
0 Comments
Single Dose of Gene Therapy AMT-061 Proves Effective in Hemophilia B
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed